Medscape
Medscape InDiscussion: Esophageal Cancer
Listen to Medscape InDiscussion: Esophageal Cancer, a podcast series where thought leaders and clinical experts share their diverse insights and practical ideas for optimizing patient care. Relevant disclosures can be found with the episode show notes on Medscape https://www.medscape.com/viewarticle/999882. The topics and discussions are planned, produced, and reviewed independently of advertisers. This podcast is intended only for US healthcare professionals.
Não deixe de visitar o site do podcast e apoiar quem o produz: www.medscape.com
Onde ouvir?
Podcasts no app Replaio Radio Em breveOs podcasts estão chegando ao app. Instale agora e seja o primeiro a descobrir um jeito totalmente novo de curtir podcasts
Instale grátis
Android 5 mi+ downloads · nota 4,8
iOS em breve
Episódios
ASCO 2024: What the ESOPEC, RENAISSANCE, and ARMANI Trials Mean for the Future of Esophageal Cancer Treatment 29.10.2024 19:37
Drs Samuel Klempner and Yelena Janjigian break down major takeaways from the clinical trial data presented at ASCO 2024. Relevant disclosures can be found with the episode show notes on Medscape https://www.medscape.com/viewarticle/999887. The topics and discussions are planned, produced, and reviewed independently of advertisers. This podcast is intended only for US healthcare professionals. Reso...
Emerging Biomarkers and Novel Therapies for Esophageal Cancer 26.09.2024 19:44
Drs Samuel Klempner and Haeseong Park discuss emerging biomarkers and novel therapies for esophageal cancer, including new data from ASCO. Relevant disclosures can be found with the episode show notes on Medscape https://www.medscape.com/viewarticle/999886. The topics and discussions are planned, produced, and reviewed independently of advertisers. This podcast is intended only for US healthcare p...
Clinical Scenarios and Approaches to Treating Locally Advanced Esophageal Adenocarcinoma 28.08.2024 19:28
Drs Samuel Klempner and Nataliya Uboha discuss the treatment of patients with locally advanced esophageal adenocarcinomas who opt to not undergo esophagostomy. Relevant disclosures can be found with the episode show notes on Medscape https://www.medscape.com/viewarticle/999885. The topics and discussions are planned, produced, and reviewed independently of advertisers. This podcast is intended onl...
Navigating Esophageal Squamous Cell Cancer From Diagnosis to Treatment 30.07.2024 23:40
Drs Samuel Klempner and Geoffrey Ku deep dive into all things esophageal squamous cell cancer, including detection, staging, and treatment. Relevant disclosures can be found with the episode show notes on Medscape https://www.medscape.com/viewarticle/999884. The topics and discussions are planned, produced, and reviewed independently of advertisers. This podcast is intended only for US healthcare...
Standard-of-Care, Second-Line, and Future Therapies for GEJ and Esophageal Adenocarcinoma 26.06.2024 20:50
Drs Samuel Klempner and Zev Wainberg discuss standard-of-care, second-line, and future therapies for GE junction, esophageal, and gastric cancers. Relevant disclosures can be found with the episode show notes on Medscape https://www.medscape.com/viewarticle/999883. The topics and discussions are planned, produced, and reviewed independently of advertisers. This podcast is intended only for US heal...
Understanding, Detecting, and Treating Gastroesophageal Junction Adenocarcinoma 26.06.2024 21:36
Drs Samuel Klempner and Yelena Janjigian provide clinical pearls for understanding, detecting, and treating GEJ adenocarcinoma. Relevant disclosures can be found with the episode show notes on Medscape https://www.medscape.com/viewarticle/999882. The topics and discussions are planned, produced, and reviewed independently of advertisers. This podcast is intended only for US healthcare professional...
Podcasts parecidos
Ouça o podcast Medscape InDiscussion: Esophageal Cancer no Replaio
Rádio e podcasts em um só app - grátis e sem cadastro. Instale hoje e não perca o lançamento
O Replaio não é o publicador dos podcasts; os nomes dos programas, as capas e o áudio pertencem aos seus autores e são distribuídos por feeds RSS públicos
